ZEISS Medical Technology has announced a strategic collaboration with Envision Health Technologies, a leading digital eye health company founded by renowned glaucoma surgeon Dr Lama A. Al-Aswad, to help advance glaucoma care through gamified virtual reality (VR) technology.
A ZEISS media release said the collaboration aimed to firmly strengthen scientific and clinical credibility in VR-based visual function testing, supported by ZEISS’ long history of innovation in perimetry.
It said the collaboration with Envision Health Technologies came at a time when demand was growing for broader access to glaucoma screenings and more flexible workflow solutions, driving enhanced industry interest in portable, software-driven approaches to visual function testing.
Through this strategic collaboration, ZEISS and Envision Health Technologies would bring together clinical expertise and software innovation to help advance clinically relevant, patient-centred technologies for modern glaucoma care.
“As glaucoma care continues to evolve, clinicians are looking for solutions that improve patient accessibility, flexibility and experience without compromising clinical confidence,” said Anuj Kalra, head of Chronic Disease Management at ZEISS Medical Technology.
“Our collaboration with Envision Health Technologies reflects ZEISS’ commitment to advancing practical, clinician-driven innovation that can help expand access to visual function testing across a range of care settings.”
Dr Al-Aswad MD, MPH, founder and CEO of Envision Health Technologies, said: “We believe the future of visual function testing should be more accessible, flexible, and patient-centred while remaining grounded in clinical rigor.
“Collaborating with ZEISS allows us to combine cutting-edge software innovation with decades of trusted market leadership in perimetry to help advance more practical solutions for real-world glaucoma care.”
Dr Al-Aswad founded Envision Health Technologies to improve outcomes for vision-threatening diseases, developing next-generation, data-driven solutions to transform how vision care is delivered, measured, and scaled.
